权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Dissection of Addiction Relevant Signal Integration by Cyfip2 through Precise Genome Engineering

Cyfip2 通过精确基因组工程解析成瘾相关信号整合

基本信息

批准号：
10450066
负责人：
VIVEK KUMAR
金额：
$ 38.28万
依托单位：
JACKSON LABORATORY
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-07-15 至 2025-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10450066
关键词：
Actins Acute Affect Alcohols Alleles Amino Acid Substitution Behavior Behavioral Binding Biochemical Biochemistry Biological Assay Biophysics Brain region CRISPR/Cas technology Cell Surface Receptors Cessation of life Cloning Cocaine Communities Complement Complex Consultations Critical Pathways Data Dideoxy Chain Termination DNA Sequencing Discipline Dissection Eating Economics Environment Event FMR1 Family Food Fragile X Syndrome Future Generations Genes Genetic Genetic Models Genome engineering Goals Gold Health Injury Intravenous Knock-out Knowledge Learning Mass Spectrum Analysis Measures Mediating Mediator of activation protein Modeling Molecular Monomeric GTP-Binding Proteins Mus Mutant Strains Mice Mutation Nicotine Palate Pathway interactions Phase Phenotype Play Process Proteins Proteomics Publishing Quantitative Trait Loci Research Research Personnel Rewards Role Series Signal Pathway Signal Transduction Signaling Protein Site Structure Sucrose Testing The Jackson Laboratory Therapeutic Intervention Translations Variant Work addiction base behavioral phenotyping chronic alcohol ingestion cocaine self-administration conditioned place preference cost design drug of abuse effective therapy genetic approach genome editing genome sequencing in vivo insight mesolimbic system mouse genetics mouse model multidisciplinary multidrug abuse mutant neurobiological mechanism new therapeutic target novel polymerization postnatal pre-clinical precise genome editing preference protein protein interaction public health relevance receptor recruit repaired response social targeted treatment therapeutically effective tool whole genome

项目摘要

PROJECT SUMMARY Addiction is an enormous economic, personal, and social burden, costing over $600 billion per year in the U.S. Understanding vulnerability to addiction, and developing effective therapies, requires identifying the genes and pathways that mediate the addiction process. Our long-term goal is to develop novel genetic models for addiction-relevant phenotypes, and use these models to characterize the genetic mechanisms of addiction. Here, we propose to extend our previous work that led to the cloning of a QTL that regulates addiction and the subsequent identification of Cyfip2 in mouse substrains as a regulator of cocaine acute and sensitized responses. We and others have since shown that this mutation regulates food reward, nicotine preference, and alcohol preference (preliminary data). In addition, we have shown that Cyfip2 regulates voluntary self- administration of cocaine in the IVSA assay, the gold standard in the addiction field. Cyfip2 is a hub for signal integration from multiple pathways, including the small GTPase RAC1, WIRS domain receptors, and Fragile X family signaling. We hypothesize that this signal integration by Cyfip2 is critical for reward behaviors. In response to PAR-19-278, we now propose to use precise genome engineering in mice to generate and functionally validate 5 variants in Cyfip2 (1-2 amino acid substitutions each) that specifically perturb each of these signal integration events. These mutations are designed using published biochemical data and in consultation with our Co- Investigator Dr. Chen, who is a leader in Cyfip biophysics and structure. In the R21 phase (Aim 1), we will leverage the mouse genetics expertise of the Jackson Laboratory to generate by CRISPR/Cas9 a set of 5 Cyfip2 signaling mutants. Specific milestones for progression to the R33 phase are (i) viability of the mutants, since the knockout of Cyfip2 is postnatal lethal, and (ii) the lack of functional off-target edits. We will then characterize these mutants comprehensively for cocaine and natural reward behavior (R33, Aim 2). To gain insight into mechanisms underlying these behaviors, we will determine the biochemical interactome of each mutant in mouse brain regions using a comprehensive mass spectrometry-based study (R33, Aim 3). The successful completion of this project will yield 5 preclinical mouse models of addiction transition for the scientific community, as well as information about specific signaling pathways that are critical for transition to addiction and that can be targeted for therapy.

项目总结